However, achieving and maintaining a healthy weight is not easy
The company said in a statement that it wants patients in the US to only have access to "FDA-approved, safe, and effective" semaglutide products, adding: "These drugs are inherently complex to compound safely, and the risks they pose to patient safety far outweigh any benefits." The Alliance for Pharmacy Compounding (APC), a trade organisation representing the compounding industry, has claimed that Novo Nordisk is "confusing the fact that the semaglutide molecule is demonstrably difficult to manufacture [] with the relative simplicity of compounding with it," according to Reuters
In the journey to achieve and maintain a healthy weight, many individuals explore various options, including lifestyle changes, diets, and medications
Months 3 to 6: Noticeable increase in density and thickness
Consistency is the most important factor in supporting your body's natural GLP-1 balance
This was an enormous boon to Novo Nordisk because it will allow the company to charge monopoly prices for Ozempic for several more years free from lower-cost generic competition
